New England Journal of Medicine· 2015Q1· Clinical trial

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

The Diabetic Retinopathy Clinical Research Network

1,586citations
Q1SCImago
2015year

Short summary

Intravitreous aflibercept, bevacizumab, and ranibizumab all improved vision in patients with diabetic macular edema, but aflibercept showed greater efficacy only in eyes with worse baseline visual acuity.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Ophthalmology

OphthalmologyMedicine